| 0 |
Interleukin-5 Antagonist [EPC] |
10802 |
15.7006 |
| 1 |
Provitamin D2 Compound [EPC] |
21036 |
0.7069 |
| 2 |
Copper Absorption Inhibitor [EPC] |
1 |
0.5000 |
| 3 |
Guanylate Cyclase-C Agonist [EPC] |
764 |
0.3682 |
| 4 |
CD38-directed Cytolytic Antibody [EPC] |
1644 |
0.2809 |
| 5 |
Endoglycosidase [EPC] |
501 |
0.2704 |
| 6 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
1708 |
0.1958 |
| 7 |
Contrast Agent for Ultrasound Imaging [EPC] |
1141 |
0.1950 |
| 8 |
Prostacyclin Receptor Agonist [EPC] |
4841 |
0.1855 |
| 9 |
Human Immunoglobulin G [EPC] |
3785 |
0.1797 |
| 10 |
Soluble Guanylate Cyclase Stimulator [EPC] |
5830 |
0.1721 |
| 11 |
Prostacycline Vasodilator [EPC] |
23704 |
0.1720 |
| 12 |
Endothelin Receptor Antagonist [EPC] |
31222 |
0.1559 |
| 13 |
Human alpha-1 Proteinase Inhibitor [EPC] |
657 |
0.1548 |
| 14 |
Adrenocorticotropic Hormone [EPC] |
134 |
0.1497 |
| 15 |
Interleukin-17A Antagonist [EPC] |
5183 |
0.1390 |
| 16 |
Parenteral Iron Replacement [EPC] |
1869 |
0.1360 |
| 17 |
Human Antihemophilic Factor [EPC] |
20 |
0.1299 |
| 18 |
Polyene Antimicrobial [EPC] |
53 |
0.1293 |
| 19 |
Anti-IgE [EPC] |
10558 |
0.1212 |
| 20 |
Phosphodiesterase 5 Inhibitor [EPC] |
16395 |
0.1211 |
| 21 |
PCSK9 Inhibitor [EPC] |
2959 |
0.1149 |
| 22 |
Blood Viscosity Reducer [EPC] |
498 |
0.1146 |
| 23 |
Leukotriene Receptor Antagonist [EPC] |
3295 |
0.1126 |
| 24 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
2109 |
0.1005 |
| 25 |
Phosphodiesterase 3 Inhibitor [EPC] |
595 |
0.0955 |
| 26 |
Thymic Stromal Lymphopoietin Blocker [EPC] |
649 |
0.0936 |
| 27 |
Gadolinium-based Contrast Agent [EPC] |
455 |
0.0927 |
| 28 |
Radiographic Contrast Agent [EPC] |
2379 |
0.0922 |
| 29 |
Diagnostic Dye [EPC] |
59 |
0.0913 |
| 30 |
Neonatal Fc Receptor Blocker [EPC] |
394 |
0.0898 |
| 31 |
Antihypoglycemic Agent [EPC] |
375 |
0.0875 |
| 32 |
Cardiac Glycoside [EPC] |
6218 |
0.0865 |
| 33 |
Histamine-1 Receptor Antagonist [EPC] |
7246 |
0.0859 |
| 34 |
Methylxanthine [EPC] |
4948 |
0.0851 |
| 35 |
Nitrofuran Antibacterial [EPC] |
1454 |
0.0826 |
| 36 |
beta Lactamase Inhibitor [EPC] |
357 |
0.0802 |
| 37 |
5-Lipoxygenase Inhibitor [EPC] |
52 |
0.0799 |
| 38 |
Aldosterone Antagonist [EPC] |
12233 |
0.0784 |
| 39 |
Loop Diuretic [EPC] |
35844 |
0.0784 |
| 40 |
Nitrate Vasodilator [EPC] |
6756 |
0.0761 |
| 41 |
Prostacycline [EPC] |
71 |
0.0761 |
| 42 |
Pyridone [EPC] |
3004 |
0.0735 |
| 43 |
Factor Xa Inhibitor [EPC] |
20217 |
0.0734 |
| 44 |
Non-Standardized Pollen Allergenic Extract [EPC] |
46 |
0.0730 |
| 45 |
Non-narcotic Antitussive [EPC] |
1228 |
0.0728 |
| 46 |
Standardized Pollen Allergenic Extract [EPC] |
46 |
0.0718 |
| 47 |
Aminoglycoside Antibacterial [EPC] |
3189 |
0.0715 |
| 48 |
P2Y12 Platelet Inhibitor [EPC] |
8548 |
0.0713 |
| 49 |
Cardiac Myosin Inhibitor [EPC] |
427 |
0.0706 |
| 50 |
Adenosine Receptor Agonist [EPC] |
515 |
0.0697 |
| 51 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
86 |
0.0694 |
| 52 |
Antirheumatic Agent [EPC] |
7283 |
0.0688 |
| 53 |
Aminosalicylate [EPC] |
6931 |
0.0688 |
| 54 |
Polymyxin-class Antibacterial [EPC] |
5 |
0.0685 |
| 55 |
Sulfonamide Antibacterial [EPC] |
271 |
0.0678 |
| 56 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
9217 |
0.0675 |
| 57 |
Chloride Channel Activator [EPC] |
641 |
0.0671 |
| 58 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
894 |
0.0668 |
| 59 |
Vitamin K [EPC] |
576 |
0.0666 |
| 60 |
Thiazide-like Diuretic [EPC] |
2839 |
0.0658 |
| 61 |
Plasma Kallikrein Inhibitor [EPC] |
157 |
0.0655 |
| 62 |
Standardized Animal Hair Allergenic Extract [EPC] |
55 |
0.0640 |
| 63 |
Expectorant [EPC] |
13001 |
0.0629 |
| 64 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
6173 |
0.0626 |
| 65 |
Stimulant Laxative [EPC] |
896 |
0.0623 |
| 66 |
HMG-CoA Reductase Inhibitor [EPC] |
23021 |
0.0616 |
| 67 |
alpha-Adrenergic Blocker [EPC] |
8586 |
0.0613 |
| 68 |
Corticosteroid [EPC] |
77898 |
0.0605 |
| 69 |
Tetracycline-class Drug [EPC] |
4224 |
0.0597 |
| 70 |
Radioactive Diagnostic Agent [EPC] |
187 |
0.0596 |
| 71 |
Angiotensin 2 Receptor Blocker [EPC] |
18918 |
0.0591 |
| 72 |
Anticholinergic [EPC] |
949 |
0.0583 |
| 73 |
Vitamin B6 Analog [EPC] |
21 |
0.0579 |
| 74 |
Nonergot Dopamine Agonist [EPC] |
902 |
0.0577 |
| 75 |
Macrolide Antimicrobial [EPC] |
3010 |
0.0573 |
| 76 |
Vitamin D2 Analog [EPC] |
408 |
0.0572 |
| 77 |
Aluminum Complex [EPC] |
1383 |
0.0571 |
| 78 |
Non-Standardized Plant Allergenic Extract [EPC] |
1003 |
0.0568 |
| 79 |
Lipid Emulsion [EPC] |
148 |
0.0560 |
| 80 |
Photoactivated Radical Generator [EPC] |
7 |
0.0547 |
| 81 |
Interleukin-6 Receptor Antagonist [EPC] |
7564 |
0.0546 |
| 82 |
Vitamin D3 Analog [EPC] |
1105 |
0.0545 |
| 83 |
Calcium [EPC] |
8122 |
0.0543 |
| 84 |
Vitamin C [EPC] |
22529 |
0.0540 |
| 85 |
Vitamin B12 [EPC] |
17542 |
0.0539 |
| 86 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
5182 |
0.0538 |
| 87 |
beta-Adrenergic Blocker [EPC] |
16455 |
0.0538 |
| 88 |
Vitamin D [EPC] |
16053 |
0.0531 |
| 89 |
alpha-Hydroxy Acid [EPC] |
115 |
0.0527 |
| 90 |
Antivenin [EPC] |
1 |
0.0526 |
| 91 |
Dihydropyridine Calcium Channel Blocker [EPC] |
17268 |
0.0526 |
| 92 |
Calcitonin [EPC] |
164 |
0.0525 |
| 93 |
Osmotic Laxative [EPC] |
15289 |
0.0517 |
| 94 |
Alkaloid [EPC] |
1379 |
0.0517 |
| 95 |
Thiazide Diuretic [EPC] |
10695 |
0.0517 |
| 96 |
Cortisol Synthesis Inhibitor [EPC] |
39 |
0.0516 |
| 97 |
Lymphocyte Growth Factor [EPC] |
65 |
0.0515 |
| 98 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
176 |
0.0514 |
| 99 |
Platelet Aggregation Inhibitor [EPC] |
29348 |
0.0513 |
| 100 |
Skin Test Antigen [EPC] |
96 |
0.0509 |
| 101 |
CD52-directed Cytolytic Antibody [EPC] |
985 |
0.0509 |
| 102 |
Bismuth [EPC] |
282 |
0.0506 |
| 103 |
Catecholamine [EPC] |
4140 |
0.0503 |
| 104 |
Carbonic Anhydrase Inhibitor [EPC] |
1013 |
0.0500 |
| 105 |
Non-Standardized Animal Hair Allergenic Extract [EPC] |
1 |
0.0500 |
| 106 |
Serotonin-3 Receptor Antagonist [EPC] |
6779 |
0.0499 |
| 107 |
Non-Standardized Insect Allergenic Extract [EPC] |
290 |
0.0499 |
| 108 |
Antiarrhythmic [EPC] |
4968 |
0.0499 |
| 109 |
Proton Pump Inhibitor [EPC] |
29210 |
0.0498 |
| 110 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
1620 |
0.0497 |
| 111 |
Xanthine Oxidase Inhibitor [EPC] |
8619 |
0.0496 |
| 112 |
Monobactam Antibacterial [EPC] |
134 |
0.0491 |
| 113 |
Paramagnetic Contrast Agent [EPC] |
224 |
0.0487 |
| 114 |
Fluoroquinolone Antibacterial [EPC] |
6313 |
0.0487 |
| 115 |
Histamine-2 Receptor Antagonist [EPC] |
6391 |
0.0486 |
| 116 |
Complement Inhibitor [EPC] |
2725 |
0.0484 |
| 117 |
Osmotic Diuretic [EPC] |
251 |
0.0480 |
| 118 |
Cannabinoid [EPC] |
387 |
0.0477 |
| 119 |
Antidote [EPC] |
3022 |
0.0477 |
| 120 |
Lead Chelator [EPC] |
4 |
0.0476 |
| 121 |
Uric Acid-specific Enzyme [EPC] |
184 |
0.0475 |
| 122 |
Macrolide Antibacterial [EPC] |
48 |
0.0474 |
| 123 |
Standardized Insect Venom Allergenic Extract [EPC] |
343 |
0.0473 |
| 124 |
Opioid Agonist [EPC] |
12870 |
0.0473 |
| 125 |
Potassium-sparing Diuretic [EPC] |
633 |
0.0473 |
| 126 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
926 |
0.0472 |
| 127 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
61724 |
0.0471 |
| 128 |
Progestin Antagonist [EPC] |
223 |
0.0467 |
| 129 |
Central alpha-2 Adrenergic Agonist [EPC] |
2486 |
0.0461 |
| 130 |
Integrin Receptor Antagonist [EPC] |
3999 |
0.0459 |
| 131 |
Cephalosporin Antibacterial [EPC] |
394 |
0.0459 |
| 132 |
Aromatase Inhibitor [EPC] |
5219 |
0.0458 |
| 133 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
4207 |
0.0456 |
| 134 |
Non-Standardized Food Allergenic Extract [EPC] |
3621 |
0.0453 |
| 135 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
437 |
0.0449 |
| 136 |
Polyene Antifungal [EPC] |
1815 |
0.0449 |
| 137 |
Microtubule Inhibitor [EPC] |
7436 |
0.0448 |
| 138 |
Plasma Volume Expander [EPC] |
138 |
0.0446 |
| 139 |
Ester Local Anesthetic [EPC] |
2223 |
0.0445 |
| 140 |
Amino Acid Hypertonic Solution [EPC] |
7 |
0.0443 |
| 141 |
Benzodiazepine [EPC] |
30382 |
0.0442 |
| 142 |
Bile Acid Sequestrant [EPC] |
539 |
0.0441 |
| 143 |
Estrogen Receptor Antagonist [EPC] |
1785 |
0.0440 |
| 144 |
Barbiturate [EPC] |
508 |
0.0439 |
| 145 |
Selective T Cell Costimulation Modulator [EPC] |
6146 |
0.0439 |
| 146 |
Nucleoside Analog Antiviral [EPC] |
3716 |
0.0435 |
| 147 |
Interleukin-23 Antagonist [EPC] |
4506 |
0.0430 |
| 148 |
CD20-directed Cytolytic Antibody [EPC] |
13619 |
0.0430 |
| 149 |
Muscle Relaxant [EPC] |
1984 |
0.0429 |
| 150 |
Non-Standardized Fungal Allergenic Extract [EPC] |
92 |
0.0428 |
| 151 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
740 |
0.0428 |
| 152 |
Vitamin A [EPC] |
2170 |
0.0427 |
| 153 |
Urease Inhibitor [EPC] |
2 |
0.0426 |
| 154 |
Anti-anginal [EPC] |
447 |
0.0424 |
| 155 |
Nicotinic Acid [EPC] |
2612 |
0.0423 |
| 156 |
Amide Local Anesthetic [EPC] |
3684 |
0.0422 |
| 157 |
Phenothiazine [EPC] |
1267 |
0.0422 |
| 158 |
HER2/neu Receptor Antagonist [EPC] |
3156 |
0.0422 |
| 159 |
Non-Standardized House Dust Allergenic Extract [EPC] |
31 |
0.0418 |
| 160 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
2378 |
0.0416 |
| 161 |
Folate Analog [EPC] |
2047 |
0.0411 |
| 162 |
Purine Antimetabolite [EPC] |
3975 |
0.0402 |
| 163 |
Human Blood Coagulation Factor [EPC] |
33 |
0.0401 |
| 164 |
Human C1 Esterase Inhibitor [EPC] |
156 |
0.0401 |
| 165 |
Benzothiazole [EPC] |
89 |
0.0400 |
| 166 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
201 |
0.0399 |
| 167 |
Sulfonylurea [EPC] |
4880 |
0.0396 |
| 168 |
Glinide [EPC] |
351 |
0.0394 |
| 169 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
545 |
0.0393 |
| 170 |
Serotonin Reuptake Inhibitor [EPC] |
3520 |
0.0392 |
| 171 |
Phenylalanine Metabolizing Enzyme [EPC] |
330 |
0.0387 |
| 172 |
Melanocortin 4 Receptor Agonist [EPC] |
11 |
0.0386 |
| 173 |
APOC-III-directed RNA Interaction [EPC] |
4 |
0.0385 |
| 174 |
Antimycobacterial [EPC] |
934 |
0.0383 |
| 175 |
Platinum-based Drug [EPC] |
10438 |
0.0381 |
| 176 |
Antiprotozoal [EPC] |
403 |
0.0379 |
| 177 |
Antiseptic [EPC] |
165 |
0.0378 |
| 178 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
263 |
0.0377 |
| 179 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
1775 |
0.0375 |
| 180 |
Small Interfering RNA [EPC] |
6 |
0.0375 |
| 181 |
Insulin [EPC] |
1738 |
0.0374 |
| 182 |
Photoenhancer [EPC] |
145 |
0.0373 |
| 183 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
4065 |
0.0373 |
| 184 |
Hematopoietic Stem Cell Mobilizer [EPC] |
55 |
0.0370 |
| 185 |
Pediculicide [EPC] |
174 |
0.0370 |
| 186 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
929 |
0.0368 |
| 187 |
Sigma-1 Agonist [EPC] |
318 |
0.0364 |
| 188 |
Rifamycin Antimycobacterial [EPC] |
127 |
0.0363 |
| 189 |
Sulfone [EPC] |
394 |
0.0362 |
| 190 |
Antimalarial [EPC] |
378 |
0.0361 |
| 191 |
Non-Standardized Chemical Allergen [EPC] |
2783 |
0.0360 |
| 192 |
Antithrombin-directed RNA Interaction [EPC] |
2 |
0.0357 |
| 193 |
Nuclear Export Inhibitor [EPC] |
310 |
0.0354 |
| 194 |
Folate Analog Metabolic Inhibitor [EPC] |
15522 |
0.0353 |
| 195 |
Nitroimidazole Antimicrobial [EPC] |
2321 |
0.0352 |
| 196 |
Central Nervous System Stimulant [EPC] |
3062 |
0.0350 |
| 197 |
Azole Antifungal [EPC] |
5446 |
0.0346 |
| 198 |
Histone Deacetylase Inhibitor [EPC] |
131 |
0.0338 |
| 199 |
Interferon gamma [EPC] |
47 |
0.0334 |
| 200 |
5-alpha Reductase Inhibitor [EPC] |
3393 |
0.0331 |
| 201 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
322 |
0.0330 |
| 202 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
120 |
0.0330 |
| 203 |
beta3-Adrenergic Agonist [EPC] |
1574 |
0.0329 |
| 204 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
239 |
0.0327 |
| 205 |
Prostaglandin E1 Analog [EPC] |
537 |
0.0324 |
| 206 |
Antifibrinolytic Agent [EPC] |
316 |
0.0321 |
| 207 |
Somatostatin Analog [EPC] |
217 |
0.0316 |
| 208 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
892 |
0.0316 |
| 209 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3692 |
0.0313 |
| 210 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3618 |
0.0313 |
| 211 |
Cholinergic Muscarinic Antagonist [EPC] |
1224 |
0.0312 |
| 212 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
16168 |
0.0312 |
| 213 |
Oxytocic [EPC] |
95 |
0.0312 |
| 214 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
2757 |
0.0308 |
| 215 |
Pyruvate Kinase Activator [EPC] |
41 |
0.0308 |
| 216 |
Isocitrate Dehydrogenase 1 Inhibitor [EPC] |
67 |
0.0308 |
| 217 |
alpha-1 Adrenergic Agonist [EPC] |
136 |
0.0307 |
| 218 |
Interleukin-12 Antagonist [EPC] |
3162 |
0.0305 |
| 219 |
Nitrogen Binding Agent [EPC] |
73 |
0.0302 |
| 220 |
Antiparasitic [EPC] |
137 |
0.0302 |
| 221 |
Sympathomimetic-like Agent [EPC] |
971 |
0.0300 |
| 222 |
Progesterone [EPC] |
708 |
0.0298 |
| 223 |
CD123 Interaction [EPC] |
16 |
0.0297 |
| 224 |
Kinase Inhibitor [EPC] |
16580 |
0.0297 |
| 225 |
CD4-directed Blocking Antibody [EPC] |
16 |
0.0296 |
| 226 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
99 |
0.0294 |
| 227 |
Selectin Blocker [EPC] |
41 |
0.0293 |
| 228 |
Antimetabolite Immunosuppressant [EPC] |
621 |
0.0291 |
| 229 |
Carnitine Analog [EPC] |
107 |
0.0291 |
| 230 |
Type I Interferon Receptor Antagonist [EPC] |
55 |
0.0286 |
| 231 |
Iron Chelator [EPC] |
837 |
0.0286 |
| 232 |
Oxaborole Antifungal [EPC] |
2 |
0.0286 |
| 233 |
Pyrethroid [EPC] |
50 |
0.0284 |
| 234 |
Glycopeptide Antibacterial [EPC] |
1846 |
0.0282 |
| 235 |
Classical Complement Pathway Inhibitor [EPC] |
9 |
0.0280 |
| 236 |
Programmed Death Ligand-1 Blocker [EPC] |
604 |
0.0280 |
| 237 |
Potassium Binder [EPC] |
421 |
0.0280 |
| 238 |
Erythroid Maturation Agent [EPC] |
73 |
0.0279 |
| 239 |
Insulin Analog [EPC] |
12511 |
0.0278 |
| 240 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
45 |
0.0278 |
| 241 |
Androgen [EPC] |
759 |
0.0278 |
| 242 |
Janus Kinase Inhibitor [EPC] |
4445 |
0.0277 |
| 243 |
Sucrose-specific Enzyme [EPC] |
5 |
0.0276 |
| 244 |
Quinolone Antimicrobial [EPC] |
272 |
0.0276 |
| 245 |
Vitamin D Analog [EPC] |
495 |
0.0275 |
| 246 |
Gonadotropin [EPC] |
60 |
0.0274 |
| 247 |
Serotonin-4 Receptor Agonist [EPC] |
18 |
0.0274 |
| 248 |
Neuraminidase Inhibitor [EPC] |
69 |
0.0273 |
| 249 |
Proteasome Inhibitor [EPC] |
3131 |
0.0273 |
| 250 |
Prostaglandin Analog [EPC] |
2540 |
0.0273 |
| 251 |
Aromatic Amino Acid [EPC] |
1645 |
0.0273 |
| 252 |
Androgen Receptor Inhibitor [EPC] |
2013 |
0.0272 |
| 253 |
Vasopressin Receptor Agonist [EPC] |
9 |
0.0272 |
| 254 |
Estrogen [EPC] |
5074 |
0.0271 |
| 255 |
Allylamine Antifungal [EPC] |
196 |
0.0270 |
| 256 |
Menin Inhibitor [EPC] |
2 |
0.0270 |
| 257 |
Erythropoiesis-stimulating Agent [EPC] |
1458 |
0.0270 |
| 258 |
Bile Acid [EPC] |
619 |
0.0268 |
| 259 |
Enzyme Stabilizer [EPC] |
31 |
0.0265 |
| 260 |
Ergot Derivative [EPC] |
130 |
0.0264 |
| 261 |
alpha-Glucosidase Inhibitor [EPC] |
129 |
0.0264 |
| 262 |
Arteriolar Vasodilator [EPC] |
2075 |
0.0264 |
| 263 |
Autologous Cellular Immunotherapy [EPC] |
151 |
0.0260 |
| 264 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
33 |
0.0260 |
| 265 |
Oxazolidinone Antibacterial [EPC] |
778 |
0.0257 |
| 266 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
46 |
0.0257 |
| 267 |
Acetylcholine Release Inhibitor [EPC] |
2536 |
0.0256 |
| 268 |
Penem Antibacterial [EPC] |
871 |
0.0254 |
| 269 |
Dopamine and Norepinephrine Reuptake Inhibitor [EPC] |
97 |
0.0252 |
| 270 |
Tricyclic Antidepressant [EPC] |
12 |
0.0251 |
| 271 |
Interleukin-17 Receptor A Antagonist [EPC] |
51 |
0.0247 |
| 272 |
Catecholamine Synthesis Inhibitor [EPC] |
2 |
0.0247 |
| 273 |
Rifamycin Antibacterial [EPC] |
893 |
0.0247 |
| 274 |
Lipopeptide Antibacterial [EPC] |
233 |
0.0245 |
| 275 |
Phosphodiesterase 4 Inhibitor [EPC] |
3989 |
0.0245 |
| 276 |
Sclerosing Agent [EPC] |
11 |
0.0244 |
| 277 |
Cholinergic Nicotinic Agonist [EPC] |
1490 |
0.0243 |
| 278 |
Dopamine-2 Receptor Antagonist [EPC] |
189 |
0.0242 |
| 279 |
Influenza A M2 Protein Inhibitor [EPC] |
381 |
0.0242 |
| 280 |
Nucleoside Metabolic Inhibitor [EPC] |
6558 |
0.0239 |
| 281 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
1242 |
0.0237 |
| 282 |
Tumor Necrosis Factor Blocker [EPC] |
23496 |
0.0235 |
| 283 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
229 |
0.0235 |
| 284 |
CD30-directed Immunoconjugate [EPC] |
243 |
0.0234 |
| 285 |
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] |
14 |
0.0233 |
| 286 |
Vasopressin V2 Receptor Antagonist [EPC] |
347 |
0.0232 |
| 287 |
CD33-directed Immunoconjugate [EPC] |
85 |
0.0232 |
| 288 |
Interleukin-1 Receptor Antagonist [EPC] |
391 |
0.0231 |
| 289 |
Parathyroid Hormone Analog [EPC] |
2594 |
0.0231 |
| 290 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
319 |
0.0230 |
| 291 |
Opioid Antagonist [EPC] |
22 |
0.0229 |
| 292 |
Gamma Secretase Inhibitor [EPC] |
21 |
0.0228 |
| 293 |
CTLA-4-directed Blocking Antibody [EPC] |
1092 |
0.0226 |
| 294 |
Tetracycline-class Antibacterial [EPC] |
178 |
0.0226 |
| 295 |
Atypical Antipsychotic [EPC] |
10148 |
0.0225 |
| 296 |
Anti-epileptic Agent [EPC] |
4933 |
0.0223 |
| 297 |
Cholinesterase Inhibitor [EPC] |
426 |
0.0223 |
| 298 |
Typical Antipsychotic [EPC] |
557 |
0.0222 |
| 299 |
CD19-directed Cytolytic Antibody [EPC] |
19 |
0.0221 |
| 300 |
Topoisomerase Inhibitor [EPC] |
1703 |
0.0221 |
| 301 |
Mood Stabilizer [EPC] |
4851 |
0.0221 |
| 302 |
Anti-coagulant [EPC] |
82 |
0.0220 |
| 303 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
2868 |
0.0220 |
| 304 |
Echinocandin Antifungal [EPC] |
179 |
0.0218 |
| 305 |
mu-Opioid Receptor Agonist [EPC] |
64 |
0.0217 |
| 306 |
Claudin 18.2-directed Cytolytic Antibody [EPC] |
33 |
0.0216 |
| 307 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
4006 |
0.0216 |
| 308 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
684 |
0.0214 |
| 309 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
134 |
0.0212 |
| 310 |
Complement 5a Receptor Antagonist [EPC] |
142 |
0.0210 |
| 311 |
Lipid-based Polyene Antifungal [EPC] |
270 |
0.0210 |
| 312 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
8 |
0.0206 |
| 313 |
Pyrimidine Synthesis Inhibitor [EPC] |
927 |
0.0206 |
| 314 |
Leukocyte Growth Factor [EPC] |
2921 |
0.0205 |
| 315 |
Interferon alfa-2b [EPC] |
38 |
0.0204 |
| 316 |
l-Thyroxine [EPC] |
1 |
0.0204 |
| 317 |
Alkylating Drug [EPC] |
4972 |
0.0204 |
| 318 |
GLP-2 Analog [EPC] |
273 |
0.0203 |
| 319 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
22 |
0.0203 |
| 320 |
Thalidomide Analog [EPC] |
10441 |
0.0200 |
| 321 |
Cholecystokinin Analog [EPC] |
3 |
0.0196 |
| 322 |
Human Immunoglobulin [EPC] |
1 |
0.0196 |
| 323 |
l-Triiodothyronine [EPC] |
1 |
0.0196 |
| 324 |
Partial Opioid Agonist [EPC] |
1830 |
0.0195 |
| 325 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
259 |
0.0195 |
| 326 |
CD3-directed Antibody [EPC] |
14 |
0.0194 |
| 327 |
Sodium Channel Blocker [EPC] |
32 |
0.0194 |
| 328 |
Melanin Synthesis Inhibitor [EPC] |
22 |
0.0193 |
| 329 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
414 |
0.0193 |
| 330 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
47 |
0.0190 |
| 331 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
195 |
0.0189 |
| 332 |
RANK Ligand Inhibitor [EPC] |
3804 |
0.0187 |
| 333 |
Survival of Motor Neuron 2 Splicing Modifier [EPC] |
78 |
0.0186 |
| 334 |
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] |
42 |
0.0185 |
| 335 |
Interleukin-6 Antagonist [EPC] |
12 |
0.0185 |
| 336 |
Anthelmintic [EPC] |
53 |
0.0182 |
| 337 |
General Anesthetic [EPC] |
794 |
0.0182 |
| 338 |
Methylating Agent [EPC] |
19 |
0.0181 |
| 339 |
Peroxisome Proliferator-activated Receptor Agonist [EPC] |
16 |
0.0178 |
| 340 |
Chemokine Receptor Type 4 Interaction [EPC] |
24 |
0.0176 |
| 341 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
858 |
0.0175 |
| 342 |
Monoamine Oxidase Inhibitor [EPC] |
54 |
0.0175 |
| 343 |
Leptin Analog [EPC] |
22 |
0.0174 |
| 344 |
BCL-2 Inhibitor [EPC] |
1092 |
0.0174 |
| 345 |
Thyroid Stimulating Hormone [EPC] |
18 |
0.0173 |
| 346 |
Asparagine-specific Enzyme [EPC] |
232 |
0.0172 |
| 347 |
Tubulin Inhibiting Agent [EPC] |
5 |
0.0172 |
| 348 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
377 |
0.0169 |
| 349 |
Vasoconstrictor [EPC] |
5 |
0.0167 |
| 350 |
Gonadotropin Releasing Hormone Receptor Antagonist [EPC] |
428 |
0.0166 |
| 351 |
Glucosylceramide Synthase Inhibitor [EPC] |
46 |
0.0163 |
| 352 |
Orexin Receptor Antagonist [EPC] |
302 |
0.0162 |
| 353 |
Complement Factor D Inhibitor [EPC] |
5 |
0.0161 |
| 354 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
83 |
0.0161 |
| 355 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
12 |
0.0159 |
| 356 |
Protease Inhibitor [EPC] |
707 |
0.0159 |
| 357 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
493 |
0.0159 |
| 358 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
51 |
0.0157 |
| 359 |
Lysosomal beta Glucuronidase [EPC] |
1 |
0.0156 |
| 360 |
Lymphocyte Activation Gene-3 Blocker [EPC] |
8 |
0.0155 |
| 361 |
Protease Activator [EPC] |
2 |
0.0155 |
| 362 |
Antileishmanial [EPC] |
6 |
0.0155 |
| 363 |
Semifluorinated Alkane [EPC] |
35 |
0.0151 |
| 364 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
245 |
0.0150 |
| 365 |
Melatonin Receptor Agonist [EPC] |
200 |
0.0150 |
| 366 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
15 |
0.0150 |
| 367 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
17 |
0.0150 |
| 368 |
Intestinal Lipase Inhibitor [EPC] |
343 |
0.0146 |
| 369 |
Antisense Oligonucleotide [EPC] |
170 |
0.0142 |
| 370 |
Estrogen Agonist/Antagonist [EPC] |
37 |
0.0142 |
| 371 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
682 |
0.0142 |
| 372 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
84 |
0.0141 |
| 373 |
Reducing and Complexing Thiol [EPC] |
35 |
0.0141 |
| 374 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
336 |
0.0140 |
| 375 |
Interferon beta [EPC] |
2602 |
0.0135 |
| 376 |
Benzodiazepine Antagonist [EPC] |
12 |
0.0135 |
| 377 |
Thrombopoietin Receptor Agonist [EPC] |
204 |
0.0134 |
| 378 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1472 |
0.0134 |
| 379 |
Cytochrome P450 3A Inhibitor [EPC] |
787 |
0.0130 |
| 380 |
Farnesyltransferase Inhibitor [EPC] |
1 |
0.0128 |
| 381 |
CCR5 Co-receptor Antagonist [EPC] |
29 |
0.0126 |
| 382 |
Hedgehog Pathway Inhibitor [EPC] |
115 |
0.0122 |
| 383 |
Bispecific HER2-directed Antibody [EPC] |
1 |
0.0122 |
| 384 |
Thyroid Hormone Receptor beta Agonist [EPC] |
28 |
0.0122 |
| 385 |
Interleukin-13 Antagonist [EPC] |
80 |
0.0119 |
| 386 |
GLP-1 Receptor Agonist [EPC] |
5200 |
0.0116 |
| 387 |
Surfactant [EPC] |
13 |
0.0112 |
| 388 |
Carboxypeptidase [EPC] |
4 |
0.0110 |
| 389 |
Hemoglobin S Polymerization Inhibitor [EPC] |
244 |
0.0109 |
| 390 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
9 |
0.0109 |
| 391 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
178 |
0.0108 |
| 392 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
19 |
0.0107 |
| 393 |
Potassium Channel Blocker [EPC] |
742 |
0.0104 |
| 394 |
Selective T Cell Costimulation Blocker [EPC] |
47 |
0.0099 |
| 395 |
Ectoparasiticide [EPC] |
38 |
0.0097 |
| 396 |
CD22-directed Immunoconjugate [EPC] |
29 |
0.0097 |
| 397 |
Neurokinin 3 Receptor Antagonist [EPC] |
22 |
0.0096 |
| 398 |
Actinomycin [EPC] |
21 |
0.0095 |
| 399 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
37 |
0.0091 |
| 400 |
Aryl Hydrocarbon Receptor Agonist [EPC] |
17 |
0.0086 |
| 401 |
Antidiarrheal [EPC] |
2 |
0.0084 |
| 402 |
Complement C5 Inhibitor [EPC] |
1 |
0.0083 |
| 403 |
Recombinant Human Growth Hormone [EPC] |
176 |
0.0080 |
| 404 |
Phosphate Binder [EPC] |
24 |
0.0079 |
| 405 |
Copper-containing Intrauterine Device [EPC] |
377 |
0.0076 |
| 406 |
Amyloid Beta-directed Antibody [EPC] |
29 |
0.0076 |
| 407 |
CD19-directed Chimeric Antigen Receptor [EPC] |
76 |
0.0075 |
| 408 |
Tyrosine Kinase 2 Inhibitor [EPC] |
21 |
0.0071 |
| 409 |
Cholinergic Muscarinic Agonist [EPC] |
17 |
0.0061 |
| 410 |
Progestin [EPC] |
1732 |
0.0059 |
| 411 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
45 |
0.0058 |
| 412 |
TRPM8 Thermoreceptor Agonist [EPC] |
36 |
0.0057 |
| 413 |
Nucleoside Analog Antifungal [EPC] |
8 |
0.0056 |
| 414 |
Humanized Monoclonal Antibody Fragment [EPC] |
8 |
0.0056 |
| 415 |
Medium-chain Triglyceride [EPC] |
3 |
0.0054 |
| 416 |
Cytolytic Agent [EPC] |
12 |
0.0051 |
| 417 |
Interleukin-31 Receptor alpha Antagonist [EPC] |
75 |
0.0047 |
| 418 |
Interferon gamma Blocker [EPC] |
1 |
0.0042 |
| 419 |
Recombinant Human Nerve Growth Factor [EPC] |
56 |
0.0041 |
| 420 |
Radioligand Therapeutic Agent [EPC] |
55 |
0.0040 |
| 421 |
Retinoid [EPC] |
909 |
0.0037 |
| 422 |
Anthracycline Topoisomerase Inhibitor [EPC] |
8 |
0.0033 |
| 423 |
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] |
6 |
0.0031 |
| 424 |
Interleukin-36 Receptor Antagonist [EPC] |
1 |
0.0025 |
| 425 |
Autologous Cultured Cell [EPC] |
1 |
0.0022 |